Innate Pharma S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
12,469.00
907.00
17,906.00
56,159.00
32,631.00
79,892
Cost of Goods Sold (COGS) incl. D&A
4,001.00
4,601.00
-
-
-
-
Gross Income
8,468.00
3,694.00
-
-
-
-
SG&A Expense
-
-
33,259.00
54,887.00
79,619.00
80,828
EBIT
6,972.00
26,563.00
17,817.00
-
51,384.00
8,338
Unusual Expense
179.00
19.00
1,322.00
81.00
3,238.00
5,051
Non Operating Income/Expense
4,081.00
6,824.00
5,472.00
3,746.00
5,414.00
1,101
Interest Expense
194.00
329.00
1,102.00
177.00
636.00
636
Pretax Income
2,468.00
19,477.00
13,751.00
3,859.00
59,418.00
11,342
Income Tax
-
-
7,045.00
8,781.00
11,033.00
14,391
Equity in Affiliates
424.00
170.00
-
-
-
-
Consolidated Net Income
2,892.00
19,647.00
6,706.00
12,640.00
48,385.00
3,049
Net Income
2,892.00
19,647.00
6,706.00
12,640.00
48,385.00
3,049
Net Income After Extraordinaries
2,892.00
19,647.00
6,706.00
12,640.00
48,385.00
3,049
Net Income Available to Common
2,892.00
19,647.00
6,706.00
12,640.00
48,385.00
3,049
EPS (Basic)
0.07
0.39
0.13
0.23
0.89
0.05
Basic Shares Outstanding
38,703.00
50,152.00
53,400.00
53,869.00
54,352.00
58,777
EPS (Diluted)
0.07
0.39
0.13
0.23
0.89
0.05
Diluted Shares Outstanding
38,703.00
50,152.00
53,400.00
55,497.00
54,352.00
59,347
EBITDA
6,092.00
24,219.00
15,162.00
1,752.00
46,988.00
936
Other Operating Expense
15,440.00
22,869.00
191.00
480.00
-
-
Non-Operating Interest Income
438.00
610.00
1,018.00
1,882.00
1,254.00
1,582
About Innate Pharma
View Profile
